1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. SUSTAINED RELEASED EXCIPIENTS MARKET BY TYPE
5.1. Introduction
5.2. Polymers
5.3. Lipids
5.4. Micrspheres
6. SUSTAINED RELEASED EXCIPIENTS MARKET BY PRODUCT TYPE
6.1. Introduction
6.2. Tablets & Capsules
6.3. Patches
6.4. Implants
6.5. Others
7. SUSTAINED RELEASED EXCIPIENTS MARKET BY ROUTE OF ADMINISTRATION
7.1. Introduction
7.2. Oral
7.3. Injectables
7.4. Transdermal
7.5. Others
8. SUSTAINED RELEASED EXCIPIENTS MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. USA
8.2.2. Canada
8.2.3. Mexico
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Others
8.4. Europe
8.4.1. Germany
8.4.2. France
8.4.3. United Kingdom
8.4.4. Spain
8.4.5. Others
8.5. Middle East and Africa
8.5.1. Saudi Arabia
8.5.2. UAE
8.5.3. Others
8.6. Asia Pacific
8.6.1. China
8.6.2. India
8.6.3. Japan
8.6.4. South Korea
8.6.5. Indonesia
8.6.6. Thailand
8.6.7. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. BASF SE
10.2. International Flavors & Fragrances, Inc.
10.3. Ashland
10.4. Evonik Industries
10.5. Croda International Plc
10.6. Gattefossé
10.7. Merck KGaA
10.8. MEGGLE GmbH & Co. KG
10.9. Roquette Frères
10.10. CD Formulation
11. APPENDIX
11.1. Currency
11.2. Assumptions
11.3. Base and Forecast Years Timeline
11.4. Key benefits for the stakeholders
11.5. Research Methodology
11.6. Abbreviations
LIST OF FIGURES
LIST OF TABLES